CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications
Go back to CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications| CVS Caremark Corp. (NYSE: CVS) | Delayed: 96.74 -0.46 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $97.20 | 52 Week High | $106.67 | |||
| Open | $96.59 | 52 Week Low | $69.30 | |||
| Day High | $97.69 | P/E | 25.80 | |||
| Day Low | $96.29 | EPS | $3.75 | |||
| Volume | 4,498,665 | |||||
